Guardant Health (GH) Set To Dominate The Growing Liquid Biopsy Market
Guardant Health, Inc. (GH) is poised for long-term growth as its revenue projections and R&D spending paint a growth story consistent with some of the best names in the industry.
Guardant Health Inc. (GH)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 268,252,000 | $215,984,055 | 6.12% | ||
| 2. | Cadian Capital Eric Bannasch | 6,930,474 | $158,985,074 | +122% | 8.13% |
| 3. | 192,029,000 | $154,612,835 | -18% | 3.21% | |
| 4. | Deep Track Capital David Kroin | 6,000,560 | $137,652,846 | +34% | 4.36% |
| 5. | Braidwell LP Alex Karnal | 3,342,124 | $76,668,325 | +20% | 2.17% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.82 | 2,187 | Officer | 12,722 | 2024-03-18 | Filing | |
| $32.78 | 750 | Officer | 5,193 | 2023-06-09 | Filing | |
| $32.68 | 2,231 | Officer | 4,443 | 2023-06-09 | Filing | |
| $26.15 | 8,600 | Officer, Director | 2,049,238 | 2023-03-15 | Filing | |
| $26.33 | 84,452 | Officer, Director | 2,040,638 | 2023-03-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $34.85 | 116 | Director | 2,810 | 2024-12-18 | Filing | |
| $35.00 | 2,320 | Director | 2,676 | 2024-12-13 | Filing | |
| $35.90 | 100 | Director | 7,548 | 2024-12-02 | Filing | |
| $29.25 | 7,000 | Officer | 17,744 | 2024-11-18 | Filing | |
| $29.90 | 2,896 | Director | 7,648 | 2024-11-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,130,654 | $301,084,191 | 0% | |
| 2. | 10,831,716 | $292,997,911 | 0% | |
| 3. | 6,178,812 | $167,136,864 | 0.13% | |
| 4. | 5,251,349 | $142,049,000 | 0.01% | |
| 5. | 4,001,803 | $108,248,771 | 0.02% |
News See All
10 Most Promising Cancer Stocks According to Hedge Funds
According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for nearly 10 million deaths in 2020, or about one in six deaths worldwide.
Guardant Health, Inc. (NASDAQ:GH) Q3 2024 Earnings Call Transcript
Operator: Hello, everyone, and welcome to the Guardant Health Q3 2024 Earnings Call. My name is Nadia and I will be coordinating the call today. [Operator Instructions].
Guardant Health, Inc. (NASDAQ:GH) Q2 2024 Earnings Call Transcript
Operator: Good afternoon. Thank you for attending today's Guardant Health Q2 2024 Earnings Call. My name is Tamiya and I will be your moderator for today's call.
Guardant Health, Inc. (NASDAQ:GH) Q1 2024 Earnings Call Transcript
Operator: Good afternoon and thank you for attending the Guardant Health Q1 2024 Earnings Call. My name is Kate and I will be the moderator for today’s call.
Guardant Health, Inc. (NASDAQ:GH) Q4 2023 Earnings Call Transcript
Operator: Good afternoon. Thank you for attending the Guardant Health Q4 2024 Earnings Call. My name is Victoria and I'll be your moderator today.
Guardant Health, Inc. (NASDAQ:GH) Q3 2023 Earnings Call Transcript
Operator: Hello, everyone, and welcome to the Guardant Health Q3 2023 Earnings Call. My name is Thrisha, and I'll be your operator today.
11 Best Immunotherapy Stocks To Buy Now
In this article, we discuss 11 of the best immunotherapy stocks to buy now.
14 Best Cancer Stocks To Buy Now
The global oncology landscape continues to evolve, with ongoing efforts to discover, develop, and provide innovative treatments aimed at improving outcomes for a growing number of patients.
Guardant Health, Inc. (NASDAQ:GH) Q2 2023 Earnings Call Transcript
Operator: Hello, everyone, and welcome to the Guardant Health Second Quarter 2023 Earnings Call. My name is Emily, and I'll be coordinating your call today. [Operator Instructions].
Billionaire Hedge Funds
